“Root%2Bcanal%2Btreatment”的搜索结果，显示 71-80 项，共有 6368 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... canal irradiation (WVSCI) will maintain the excellent 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control ...

2. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two ... Medical management will be uniform for all randomized treatment groups and will be ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

4. 妙佑医疗国际眼科- 临床试验

   The purpose of this study is to systematically and prospectively record accurate and complete data regarding the clinical presentation, treatment ... Go to page 2 ...

5. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two ... Medical management will be uniform for all randomized treatment groups and will be ...

6. 妙佑医疗国际眼科- 临床试验

   The study proposes to form a consortium of autoimmunity of the optic nerve with the goal of improving diagnosis and treatment of these conditions. ... 2: The ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF.

8. 肺癌计划- 临床试验- 妙佑医疗国际

   Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

9. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two ... Medical management will be uniform for all randomized treatment groups and will be ...

10. 脑肿瘤项目- 临床试验- 妙佑医疗国际

    Targeted Therapy Directed by Genetic Testing in Treating ... Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment ... Go to page 22 ...